MedTrace Logo

Narrow-band Imaging Diagnostic Classification System for Bladder Tumors

NCT05611762 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1064

Last updated 2022-12-19

No results posted yet for this study

Summary

The goal of this observational study is to learn about the morphological characteristics of different bladder lesions under narrow-band imaging（NBI） techniques in All patients requiring cystoscopy and biopsy. The main questions it aims to answer are:

1. To clarify the characteristics of different bladder lesions under NBI and to establish a diagnostic classification system for bladder tumors under NBI based on pathological findings.
2. Verify the accuracy of this classification system. Participants will record the morphological characteristics under ordinary white light and NBI during cystoscopy, analyze the pathological characteristics of different tissues corresponding to the NBI characteristics, establish a diagnostic classification system for bladder tumor under NBI using pathological biopsy as the diagnostic standard, and then verify the accuracy of this classification standard through clinical.

Conditions

  • Urinary Bladder Neoplasms

Sponsors & Collaborators

  • Qilu Hospital of Shandong University

    collaborator OTHER

  • The Second Hospital of Shandong University

    collaborator OTHER

  • Shandong Provincial Hospital

    collaborator OTHER_GOV

  • Yantai Yuhuangding Hospital

    collaborator OTHER

  • Qianfoshan Hospital

    collaborator OTHER

  • Qilu Hospital of Shandong University (Qingdao)

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05611762 on ClinicalTrials.gov